首页> 外国专利> Substituted 4,5-dihydro-6-4-(1H-imidazol-1-yl)phenyl-3(2H)- pyridazinones and 6-4-(1H-imidazol-1-yl)phenyl-3(2H)-pyridazinones

Substituted 4,5-dihydro-6-4-(1H-imidazol-1-yl)phenyl-3(2H)- pyridazinones and 6-4-(1H-imidazol-1-yl)phenyl-3(2H)-pyridazinones

机译:取代了4,5-二氢-6- [4-(1H-咪唑-1-基)苯基] -3(2H)-哒嗪酮和6- [4-(1H-咪唑-1-基)苯基] -3( 2H)-吡嗪酮

摘要

Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)-phenyl]-3(2H)- pyridazinone compounds and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)- pyridazinone compounds and pharmaceutically acceptable salts thereof are useful as cardiotonic agents.PPSaid compounds cause a significant increase in myocardial contractility in the anesthetized dog. Said compounds are produced by reacting substituted -oxo- benzenebutanoic acids with suitably substituted hydrazines to provide 4,5- dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones which are dehydrogenated to 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones. P PBoth the intermediate 4,5-dihydro-6-[4-(1H-imidazol-1-yl) phenyl]-3(2H)-pyridazinones and the 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)- pyridazinones are useful as cardiotonic agents.
机译:取代4,5-二氢-6- [4-(1H-咪唑-1-基)-苯基] -3(2H)-哒嗪酮化合物和6- [4-(1H-咪唑-1-基)苯基]- 3(2H)-哒嗪酮化合物及其药学上可接受的盐可用作强心剂。所述化合物引起麻醉狗的心肌收缩力的显着增加。所述化合物是通过使取代的-氧-苯丁酸与适当取代的肼反应制备的,以提供4,5-二氢-6- [4-(1H-咪唑-1-基)苯基] -3(2H)-吡啶并壬酮进行脱氢。生成6- [4-(1H-咪唑-1-基)苯基] -3(2H)-哒嗪酮。

两者都是中间体4,5-二氢-6- [4-(1H-咪唑- 1-基)苯基] -3(2H)-哒嗪酮和6- [4-(1H-咪唑-1-基)苯基] -3(2H)-哒嗪酮可用作强心剂。

著录项

  • 公开/公告号US4353905A

    专利类型

  • 公开/公告日1982-10-12

    原文格式PDF

  • 申请/专利权人 WARNER-LAMBERT COMPANY;

    申请/专利号US19810302181

  • 发明设计人 ILA SIRCAR;JAMES A. BRISTOL;

    申请日1981-09-17

  • 分类号C07D403/10;A61K31/50;

  • 国家 US

  • 入库时间 2022-08-22 12:08:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号